Morgan Stanley’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.4M | Buy |
|
|||||
|
2025
Q1 | $17M | Buy |
|
|||||
|
2024
Q4 | $25M | Sell |
|
|||||
|
2024
Q3 | $50.8M | Buy |
|
|||||
|
2024
Q2 | $28.4M | Buy |
|
|||||
|
2024
Q1 | $19M | Sell |
|
|||||
|
2023
Q4 | $42M | Buy |
|
|||||
|
2023
Q3 | $20.2M | Sell |
|
|||||
|
2023
Q2 | $31.8M | Buy |
|
|||||
|
2023
Q1 | $13.1M | Buy |
|
|||||
|
2022
Q4 | $12M | Sell |
|
|||||
|
2022
Q3 | $20.9M | Buy |
|
|||||
|
2022
Q2 | $12.4M | Sell |
|
|||||
|
2022
Q1 | $22.7M | Buy |
|
|||||
|
2021
Q4 | $12.8M | Sell |
|
|||||
|
2021
Q3 | $19.4M | Sell |
|
|||||
|
2021
Q2 | $33.8M | Sell |
|
|||||
|
2021
Q1 | $26.4M | Buy |
|
|||||
|
2020
Q4 | $18.4M | Sell |
|
|||||
|
2020
Q3 | $10.9M | Sell |
|
|||||
|
2020
Q2 | $7.71M | Buy |
|
|||||
|
2020
Q1 | $2.72M | Sell |
|
|||||
|
2019
Q4 | $4.33M | Buy |
|
|||||
|
2019
Q3 | $2.5M | Buy |
|
|||||
|
2019
Q2 | $3.03M | Buy |
|
|||||
|
2019
Q1 | $3.06M | Sell |
|
|||||
|
2018
Q4 | $4.22M | Buy |
|
|||||
|
2018
Q3 | $4.06M | Buy |
|
|||||
|
2018
Q2 | $1.79M | Buy |
|
|||||
|
2018
Q1 | $1.62M | Buy |
|
|||||
|
2017
Q4 | $27K | Buy |
|